
Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
Keywords: HCV, hepatitis C virus; Peg IFN-α, pegylated interferon-alpha; DAAs, direct-acting antiviral agents; CHC, chronic hepatitis C; AEs, adverse events; IFN-α, interferon-alpha; SVR, sustained virologic response; LP, lichen planus; DRESS, drug reaction with eo